ProShares Ultra NASDAQ Biotechnology
35 hedge funds and large institutions have $28.7M invested in ProShares Ultra NASDAQ Biotechnology in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.
Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
12
Increased
10
Reduced
8
Closed
7
Calls
$17.4M
Puts
$17.3M
Net Calls
+$122K
Net Calls Change
-$4.59M